MoneyAM

Proteome Sciences Share Price (PRM)

0.00 0.00 (0.00%) delayed: 5:44AM BST
Bid price 0.00 Open price 0.00
Ask price 0.00 Prev close 35.50
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Proteome Sciences share prices, Proteome Sciences stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Proteome Sciences Level 2 Data, indepth research tools and investor commentary for Proteome Sciences (PRM) and other London Stock Exchange equities.

Proteome Sciences Share Price Chart

Advanced Charts >>

Register now for FREE Proteome Sciences share price charts

Proteome Sciences Share Price Information

Name Proteome Sciences Epic PRM
Sector Pharmaceuticals & Biotechnology ISIN GB0003104196
Activites Proteome Sciences plc applies high sensitivity proteomics to identify and characterise differential protein expression in diseases for diagnostic, prognostic and therapeutic applications. It has to date developed sensitive blood assays for stroke, vCJD, BSE, solid organ transplant rejection and Alzheimer's disease. The main focus of its research currently addresses neurological, neurodegenerative, diabetes/obesity, oncology and cardiovascular conditions. In addition to its own proprietary biomarkers, Proteome Sciences has developed ProteoShop ® (Proteome Sciences High Output Proteomics), a tool box that offers high sensitivity and high throughput gel and gel-free proprietary technologies for the identification of potential biomarkers and drug targets. These include specialisation in membrane proteins and protein phosphorylation. The Company has developed a range of specialist reagents to improve the performance and quantitation of protein separation and characterisation with mass spectrometry, bioinformatics, statistics and pattern recognition. These include Sensitizer ®, PST ®, qPST ® and TMT ®. Commercialisation is being actively pursued across the portfolio of the Company's programmes and technologies with licensing deals signed in biomarkers for Stroke and TSEs and for ProteoSHOP ®. Index n/a

Proteome Sciences Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 98.69
Market Capitalisation (£m) 77.61 Gross Gearing (%) 111.04
Shares in issue (m) 214.11 Debt Ratio -64.95
P/E Ratio -16.40 Debt-to-Equity Ratio 0.04
Total dividends per share (p) 0.00 Assets / Equity Ratio -9.06
Dividend Yield (%) 0.00 Price to book value -100.79
Dividend cover (x) 0.00 ROCE -0.70
Earning per share (p) -2.21 EPS Growth (%) -7.28
52 week high / low 73.00 / 27.00 DPS Growth (%) n/a

Proteome Sciences Director Deals

Dec.Date Type Director Pos No. of Shares
24/02/2014 PLAC Christopher Pearce CEO 3,571,429
06/07/2010 PLAC R Steve Harris CH 24,199
06/07/2010 PLAC James Malthouse FD 130,031
06/07/2010 PLAC Prof William Dawson NED 5,248
31/05/2008 EXR Christopher Pearce CEO 450,000

More Proteome Sciences Director Deals >>

Proteome Sciences Company News

07:00 01/04/2014

Blocklisting Interim Review

/* */ RNS Number : 1217D Proteome Sciences PLC 01 April 2014        Proteome Sciences plc   Block Admission return       Name of company: Proteome Sciences plc Name of scheme:...

07:00 27/03/2014

Pancreatic Cancer Study in PLOS ONE

/* */ RNS Number : 2948D Proteome Sciences PLC 27 March 2014            Proteome Sciences plc ("Proteome" or the "Company") SysQuant ® - Pancreatic Cancer Study in PLOS ONE   27 th March, 2014 -...

More Proteome Sciences Company News >>

Register now for FREE Proteome Sciences company news

Proteome Sciences Share Price Discussions

3 months ago

proteome sciences........opinions (PRM)

Does anyone have an opinion on PRM. No comparable news for a while. Price seems to be sliding once again.

more than 1 year ago

Does anyone smell a rat PRM (PRM)

The price has fallen quite significantly over recent weeks then they bring out todays statement. Other statements have said the fundamentals haven't changed. Its not all doom and gloom but we will be waitng much longer for progress to be made. What do you think?

more than 1 year ago

MAJOR ANNOUNCEMENT EXPECTED VERY SHORTLY RE:- LICENSING DEAL (PRM)

WELL INFORMED CITY SOURCE REVEALED IMPORTANT MEETING TOOK PLACE WITHIN LAST WEEK AND A MAJOR DEAL WILL BE ANNOUNCED WITHIN DAYS.THE SHARES WILL BE RE-RATED SUBSTANTIALLY FOLLOWING THE ANNOUNCEMENT.

Register now for FREE Proteome Sciences share price discussions